• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT BINAX NOW COVID 19 ANTIGEN CARD; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT BINAX NOW COVID 19 ANTIGEN CARD; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Lot Number 387033
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/02/2023
Event Type  Other  
Event Description
Binaxnow covid-19 ag card use for covid-19 under emergency use authorization (eua): patient received a binaxnow covid-19 ag test that was inadvertently run with fluorometholone 0.1% ophthalmic solution rather than test reagent solution (a different patient's medication was not returned to nursing home med cart- likely mistaken for binaxnow reagent bottle when left in testing kit, the bottles look very similar).The invalid but documented result of the antigen test was positive.The error was not identified until the ophthalmic solution was discovered in the test kit and 2 binaxnow tests using the ophthalmic solution in place of reagent were intentionally completed and showed positive results compared to correctly run negative control tests x2.A pcr follow-up test of the patient confirmed that the patient was covid-19 negative via pcr.The patient remained asymptomatic for covid-19 throughout.Negative outcomes for the patient included 6 days of unnecessary transmission-based precautions/isolation and sample collection for the pcr test.Follow up testing after discovery of likely invalid binaxnow covid-19 ag test.Admission to nursing home from hospital, (day 2 after).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAX NOW COVID 19 ANTIGEN CARD
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
ABBOTT
MDR Report Key16796165
MDR Text Key313920570
Report NumberMW5116920
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Lot Number387033
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/21/2023
Patient Sequence Number1
Treatment
FLUOROMETHOLONE OPHTHALMIC SUSPENSION, USP 0.1%, MFR: PACIFIC PHARMA, UID: 60758-880-05
Patient Age77 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-